HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.
HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.
复制标题
对自己收集的宫颈阴道灌洗标本进行 HPV 检测作为未参加宫颈筛查的女性的筛查方法:队列研究。
DOI:
10.1136/bmj.c1040
复制
发表时间:
2010-03-11
影响因子:
105.7
通讯作者:
Meijer, Chris J. L. M.
中科院分区:
文献类型:
--
作者:
Gok, Murat;Heideman, Danielle A. M.;van Kemenade, Folkert J.;Berkhof, Johannes;Rozendaal, Lawrence;Spruyt, Johan W. M.;Voorhorst, Feja;Belien, Jeroen A. M.;Babovic, Milena;Snijders, Peter J. F.;Meijer, Chris J. L. M.
Objective To determine whether offering self sampling of cervicovaginal material for high risk human papillomavirus (HPV) testing is an effective screening method for women who do not attend regular cervical screening programmes. Design Cohort study (the PROHTECT trial). Settings Noord-Holland and Flevoland regions of the Netherlands, December 2006 to December 2007, including 13 laboratories, gynaecologists, and more than 800 general practitioners. Participants 28 073 women who had not responded to two invitations to the regular cervical screening programme: 27 792 women were assigned to the self sampling group and invited to submit a self collected cervicovaginal sample for HPV testing; 281 were assigned to the recall control group and received a second re-invitation for conventional cytology. Intervention Women with a positive result on the high risk HPV test on their self sample material were referred to their general practitioner. Women with abnormal results on cytology were referred for colposcopy. Women with normal results on cytology were re-evaluated after one year by cytology and high risk HPV testing and referred for colposcopy if either result was positive. Main outcome measures Attendance rate in both groups and yield of cervical intraepithelial neoplasia grade II/III or worse (≥CIN II/≥CIN III) in self sampling responders. Results The compliance rate in the self sampling group was significantly higher than in the control group (crude 26.6% v 16.4%, P<0.001; adjusted 27.5% v 16.6%, P<0.001). The number of detected ≥CIN II and ≥CIN III lesions in self sampling responders was 99 (1.3%) and 76 (1.0%), respectively. Self sampling responders who had not participated in the previous round of screening (43%) had increased relative risks of ≥CIN II (2.04, 95% confidence interval 1.27 to 3.28) and ≥CIN III (2.28, 1.31 to 3.96) compared with self sampling women who had been screened in the previous round (57%). Conclusions Offering self sampling by sending a device for collecting cervicovaginal specimens for high risk HPV testing to women who did not attend regular screening is a feasible and effective method of increasing coverage in a screening programme. The response rate and the yield of high grade lesions support implementation of this method for such women. Trial registration ISRCTN45527158.
登录
查看更多内容
影响因子:
3.4
作者:
Bulk, S;van Kemenade, FJ;Meijer, CJLM
通讯作者:
Meijer, CJLM
影响因子:
168.9
作者:
Bulkmans, N. W. J.;Berkhof, J.;Meijer, C. J. L. M.
通讯作者:
Meijer, C. J. L. M.
影响因子:
9.4
作者:
Hesselink, A. T.;Bulkmans, N. W. J.;Snijders, P. J. F.
通讯作者:
Snijders, P. J. F.
影响因子:
7.2
作者:
Sawaya, GF;Grimes, DA
通讯作者:
Grimes, DA
影响因子:
6.4
作者:
Bais, Aagje G.;van Kemenade, Folkert J.;Meijer, Chris J. L. M.
通讯作者:
Meijer, Chris J. L. M.